These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15952536)

  • 21. [Long-term effects of glatiramer acetate in multiple sclerosis].
    Brochet B
    Rev Neurol (Paris); 2008 Nov; 164(11):917-26. PubMed ID: 18790510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent insights into the mechanism of action of glatiramer acetate.
    Kala M; Miravalle A; Vollmer T
    J Neuroimmunol; 2011 Jun; 235(1-2):9-17. PubMed ID: 21402415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Glatiramer acetate (Copaxone) influence on different stages of multiple sclerosis pathogenesis].
    Shmidt TE; Zhuchenko TD; Iakhno NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; (Spec No 2):79-82. PubMed ID: 12938640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of glatiramer acetate (Copaxone) on the immunophenotypic and cytokine profile and BDNF production in multiple sclerosis: a longitudinal study.
    Blanco Y; Moral EA; Costa M; Gómez-Choco M; Torres-Peraza JF; Alonso-Magdalena L; Alberch J; Jaraquemada D; Arbizu T; Graus F; Saiz A
    Neurosci Lett; 2006 Oct; 406(3):270-5. PubMed ID: 16934924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment with glatiramer acetate induces specific IgG4 antibodies in multiple sclerosis patients.
    Farina C; Vargas V; Heydari N; Kümpfel T; Meinl E; Hohlfeld R
    J Neuroimmunol; 2002 Feb; 123(1-2):188-92. PubMed ID: 11880163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disease-modifying drugs for the early treatment of multiple sclerosis.
    Flachenecker P
    Expert Rev Neurother; 2004 May; 4(3):455-63. PubMed ID: 15853542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Humoral and cellular immune responses to Copolymer 1 in multiple sclerosis patients treated with Copaxone.
    Brenner T; Arnon R; Sela M; Abramsky O; Meiner Z; Riven-Kreitman R; Tarcik N; Teitelbaum D
    J Neuroimmunol; 2001 Apr; 115(1-2):152-60. PubMed ID: 11282165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Demonstration of equivalence of a generic glatiramer acetate (Glatopa™).
    Anderson J; Bell C; Bishop J; Capila I; Ganguly T; Glajch J; Iyer M; Kaundinya G; Lansing J; Pradines J; Prescott J; Cohen BA; Kantor D; Sachleben R
    J Neurol Sci; 2015 Dec; 359(1-2):24-34. PubMed ID: 26671082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological parameters in patients with epilepsy.
    Bostantjopoulou S; Hatzizisi O; Argyropoulou O; Andreadis S; Deligiannis K; Kantaropoulou M; Kazis A; Kyrazis G; Routsonis K
    Funct Neurol; 1994; 9(1):11-5. PubMed ID: 8082848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Disorders of specific humoral immunological response in children with febrile seizures].
    Zubiel M; Wendorff J; Zeman K; Tosik M
    Neurol Neurochir Pol; 2004; 38(1 Suppl 1):S39-44. PubMed ID: 15045866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review of the clinical efficacy profile of copolymer 1: new U.S. phase III trial data.
    Johnson KP
    J Neurol; 1996 Apr; 243(4 Suppl 1):S3-7. PubMed ID: 8965118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of oral glatiramer acetate on clinical and MRI-monitored disease activity in patients with relapsing multiple sclerosis: a multicentre, double-blind, randomised, placebo-controlled study.
    Filippi M; Wolinsky JS; Comi G;
    Lancet Neurol; 2006 Mar; 5(3):213-20. PubMed ID: 16488376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A comparative analysis of rebif 22-mcg and copaxone efficacy in multiple sclerosis].
    Zavalishin IA; Peresedova AV; Stoĭda NI; Rebrova Oi; Zakharova MN; Adarcheva LS; Niazbekova AS; Askarova LSh; Baĭdina EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Spec No 3():111-5. PubMed ID: 17172245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variation of serum uric acid levels in multiple sclerosis during relapses and immunomodulatory treatment.
    Guerrero AL; Martín-Polo J; Laherrán E; Gutiérrez F; Iglesias F; Tejero MA; Rodríguez-Gallego M; Alcázar C
    Eur J Neurol; 2008 Apr; 15(4):394-7. PubMed ID: 18312403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab.
    Rossi S; Motta C; Studer V; De Chiara V; Barbieri F; Monteleone F; Fornasiero A; Coarelli G; Bernardi G; Cutter G; Stüve O; Salvetti M; Centonze D
    Eur J Neurol; 2013 Jan; 20(1):87-94. PubMed ID: 22741530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Results of open post-registration clinical trials of copaxone in patients with multiple sclerosis].
    Zavalishin IA; Gusev EI; Iakhno NN; Ronkin MA; Shmidt TE; Demina TL; Kugoev AI; Adarcheva LS; Niiazbekova AS; Zakharova MN; Peresedova AB; Toropina GG; Klishevskaia LA; Maksimenko IM; Krotenkova MV; Konovalov SN; Rebrova OIu; Zhuchenko TD
    Zh Nevrol Psikhiatr Im S S Korsakova; 2002; Suppl():59-64. PubMed ID: 12418394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in serum immunoglobulin concentrations in patients with multiple sclerosis during the treatment with ACTH.
    Maciejek Z; Rebeś Z; Kubasiewicz B
    Arch Immunol Ther Exp (Warsz); 1981; 29(2):141-4. PubMed ID: 6272663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current treatment of multiple sclerosis].
    Csépány T
    Lege Artis Med; 2011 Feb; 21(2):97-104. PubMed ID: 21710707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression of CD4+ CD25+ regulatory T cells in peripheral blood and salivary gland of patients with primary Sjögren's syndrome].
    Li XM; Li XP; Qian L; Wang GS; Zhang H; Zhei ZM; Li Q; Chen K; Wang XQ; Wang YP
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1034-6. PubMed ID: 17672966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunological aspects of aphthous stomatitis].
    Koridze Kh; Ladashvili L; Taboridze I; Bakradze M
    Georgian Med News; 2007 Oct; (151):37-9. PubMed ID: 18071210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.